uracil has been researched along with Adenocarcinoma of Lung in 4 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Noro, R | 1 |
Honda, K | 1 |
Nagashima, K | 1 |
Motoi, N | 1 |
Kunugi, S | 1 |
Matsubayashi, J | 1 |
Takeuchi, S | 1 |
Shiraishi, H | 1 |
Okano, T | 1 |
Kashiro, A | 1 |
Meng, X | 1 |
Yoshida, Y | 1 |
Watanabe, S | 1 |
Usuda, J | 1 |
Inoue, T | 1 |
Wilber, H | 1 |
Ikeda, N | 1 |
Seike, M | 1 |
Gemma, A | 1 |
Kubota, K | 1 |
Miyata, R | 1 |
Hamaji, M | 1 |
Nakakura, A | 1 |
Morita, S | 1 |
Shimazu, Y | 1 |
Ishikawa, M | 1 |
Kayawake, H | 1 |
Menju, T | 1 |
Sakaguchi, Y | 1 |
Sonobe, M | 1 |
Takahashi, M | 1 |
Aoyama, A | 1 |
Sumitomo, R | 1 |
Huang, CL | 1 |
Kono, T | 1 |
Miyahara, R | 1 |
Matsumoto, A | 1 |
Katakura, H | 1 |
Fukada, T | 1 |
Sakai, H | 1 |
Kobayashi, M | 1 |
Okumura, N | 1 |
Date, N | 1 |
Fujinaga, T | 1 |
Miyamoto, E | 1 |
Nakagawa, T | 1 |
Date, H | 1 |
Kawamoto, N | 1 |
Okita, R | 1 |
Hayashi, M | 1 |
Okada, M | 1 |
Inokawa, H | 1 |
Nagahiro, I | 1 |
Miyamoto, M | 1 |
Sugiyama, H | 1 |
Kawai, T | 1 |
Toda, K | 1 |
Nobuhisa, T | 1 |
Endou, Y | 1 |
Watanabe, T | 1 |
Matsumoto, Y | 1 |
Watanabe, N | 1 |
Kai, K | 1 |
Satou, S | 1 |
1 review available for uracil and Adenocarcinoma of Lung
Article | Year |
---|---|
[A case of drug-induced eosinophilic pneumonia due to tegafur-uracil(UFT®)].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Female | 2011 |
1 trial available for uracil and Adenocarcinoma of Lung
Article | Year |
---|---|
Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2023 |
2 other studies available for uracil and Adenocarcinoma of Lung
Article | Year |
---|---|
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Topics: Actinin; Adenocarcinoma of Lung; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, T | 2022 |
Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
Topics: Adenocarcinoma of Lung; Chemotherapy, Adjuvant; Humans; Lung Neoplasms; Male; Middle Aged; Pericardi | 2021 |